Annual Drug Patent Expirations for NEXPLANON
Nexplanon is a drug marketed by Organon Usa Inc and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.
This drug has seventy-nine patent family members in thirty-two countries.
The generic ingredient in NEXPLANON is etonogestrel. One supplier is listed for this compound. Additional details are available on the etonogestrel profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
